InvestWiser

Medistim ASA

MEDIOslo BørsHealthcareMarket value 5.8 bn NOK
317.00NOK −0.6%
last day · Price as of 19 November 2026

The answer first

Does Medistim beat the market?

Yes, Medistim has beaten the market over the last year.

Medistim+32.3%Oslo Børs (OSEBX)+29.5%
  • The ranking · Quality, value and trend combined

    Better than 84% of Nordic stocks

    • Quality99
    • Value9
    • Trend95

    No. 20 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash Medistim keeps must grow about 10% a year for 10 years.

Max for seven days

Follow Medistim with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Medistim

From today, at a price of 317.00 NOK. Write why you follow Medistim, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Medistim

Your first answer is free, no account needed.

Do you own Medistim, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Medistim and a few more. Free, no card.

Past year against the exchange and Super Stock
Medistim+32.3%Oslo Børs (OSEBX)+29.5%Super Stock+44.6%
17 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Medistim has risen 32.3% over the past year, including dividends.
  • Overall, Medistim ranks better than 84% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 64.6%. The price is 8.4% below its peak now.

Who owns Medistim? See the major shareholders and their stakes

What do analysts think of Medistim?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

84

Quality, value and trend together. Better than 84% of Nordic stocks.

No. 20 of 195 in healthcare

Quality99
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 4 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.14
  • Asset turnoverSales divided by everything the company owns1.25
  • Return on equityProfit divided by equity+39.2%
  • Cash conversionOperating cash flow divided by profit1.19

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value9
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 139 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity12.7
  • P/SPrice divided by sales7.3
  • P/EPrice divided by earnings32.4
  • P/CFPrice divided by operating cash flow27.2

The ranking is built on P/E, P/B and P/S.

Trend95
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 13 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+30.7%
  • 6 months+33.4%
  • 9 months+61.6%
  • 12 months+32.3%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+13.2%
3 years, per year
+22.7%
5 years, per year
−0.5%
10 years, per year
+19.2%
Largest fall, 3 years
−64.6%
From a peak to the bottom
From the peak now
−8.4%
How far the price is from the peak
Volatility, 1 year
34.0%
How much the price swings over a year
Beta, 1 year
0.11
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Medistim

9 funds we follow own Medistim. The share is how much of the fund the stock makes up.

  • Norway3
  • Sweden6

From the funds' latest known holdings.

About Medistim

Medistim ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 160 employees.

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use.

See the full analysis of Medistim.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Oslo Børs

Explore the stock market